Bicalox™ 50 mg comprimate filmate 摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bicalox™ 50 mg comprimate filmate

eris pharmaceuticals (australia) pty ltd - bicalutamidum - comprimate filmate - 50 mg

CASODEX 50 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

casodex 50 mg

astrazeneca uk limited - bicalutamidum - compr. film. - 50mg - antagonisti hormonali si substante inrudite antiandrogeni

CASODEX 150 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

casodex 150 mg

astrazeneca uk ltd. - bicalutamidum - compr. film. - 150mg - antagonisti hormonali si substante inrudite antiandrogeni

Lojuxta 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

lojuxta

amryt pharmaceuticals dac - lomitapida - hipercolesterolemia - agenți de modificare a lipidelor - lojuxta este indicat ca adjuvant la o dieta de low‑fat şi alte lipid‑lowering cu muzica medicamentelor cu sau fără low density lipoprotein (ldl) afereză la pacienţii adulţi cu hipercolesterolemie homozigotă familială (hofh). confirmarea genetică a hofh ar trebui să fie obținute ori de câte ori este posibil. alte forme de primar hyperlipoproteinaemia și cauzele secundare de hipercolesterolemie (e. sindrom nefrotic, hipotiroidism) trebuie să fie excluse.

Axastrol comprimate filmate 1 mg 摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

axastrol comprimate filmate 1 mg

grindeks sa - anastrozolum - comprimate filmate - 1 mg

Firmagon 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostate neoplasme - terapia endocrină - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Xtandi 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostate neoplasme - terapia endocrină - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

ARIMIDEX 1 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arimidex 1 mg

astrazeneca uk limited - anastrozolum - compr. film. - 1mg - antagonisti hormonali si substante inrudite inhibitori enzimatici

ZOLADEX 3,6 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zoladex 3,6 mg

astrazeneca uk limited - goserelinum - implant - 3,6mg - hormoni si substante inrudite analogi de gonadorelina

ZOLADEX LA 10,8 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zoladex la 10,8 mg

astrazeneca uk ltd. - goserelinum - implant - 10,8 mg - hormoni si substante inrudite analogi de gonadorelina